Hydrocodone Bitartrate/Ibuprofen

酒石酸氢可酮/布洛芬

Report date: 2025/05/27 14:52:45

Base Information

Drug NameHydrocodone Bitartrate/Ibuprofen
Drug Alias Namehydrocodone and ibuprofen布洛芬/酒石酸氢可酮Ibuprofen/Hydrocodone BitartrateHydrocodone bitartrate - ibuprofenHydrocodone Bitartrate and Ibuprofen +[8] 
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsOpioid receptors agonists
TargetsOpioid receptorsCyclooxygenases
Therapy Area/IndicationsAcute PainPainHand, Foot and Mouth Disease
Global Approved IndicationsAcute Pain
Approved Indications in ChinaAcute Pain
Original Approved Country/TerritoryUnited States
Original Approved Date1997/09/23
Country/TerritoryUnited StatesMainland China
CombinationsYes IbuprofenHydrocodone Bitartrate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAbbvie Inc
China Registration ClassN/A

Develop Information

Active CompaniesYichang Humanwell Pharmaceutical Co Ltd
Inactive CompaniesBeijing Minhai Biotechnology Co LtdAbbvie IncShenzhen Kangtai Biological Products Co Ltd
Active IndicationsAcute PainPain
Inactive IndicationsHand, Foot and Mouth Disease

Other Information

ATC CodeM01AE51
Related LinksKEGG